High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
Michot JM, Annereau M, Danu A, Legoupil C, Bertin L, Chahine C, Achab N, Antosikova A, Cerutti A, Rossignol J, Ghez D, Willekens C, Dartigues P, Lazarovici J, Lemare F, Ribrag V.
Michot JM, et al. Among authors: bertin l.
Eur J Haematol. 2020 Apr;104(4):281-290. doi: 10.1111/ejh.13369. Epub 2020 Jan 28.
Eur J Haematol. 2020.
PMID: 31838764
Clinical Trial.